Cyber criminals accessed emails and other data from November involving the assessment of experimental COVID-19 vaccines, according to the European Medicines Agency, which cited its ongoing probe.
“We have seen that some of the correspondence has been published not in its integrity and original form and, or with, comments or additions by the perpetrators," said the Netherlands-based watchdog.